Mitochondrial Dysfunction Associated with mtDNA Mutation: Mitochondrial Genome Editing in Atherosclerosis Research

Area of Science:

• Cardiovascular Research
• Mitochondrial Biology
• Genetics

Background:

• Atherosclerosis is linked to mitochondrial dysfunction, impacting cellular and metabolic health.
• Mitochondrial DNA (mtDNA) mutations, like the atherosclerosis-associated m.15059G>A, are implicated in disease pathogenesis.
• Understanding the role of specific mtDNA mutations is crucial for addressing cardiovascular diseases.

Purpose of the Study:

• To investigate the functional impact of the atherosclerosis-associated m.15059G>A mutation on mitochondrial function.
• To determine if eliminating the m.15059G>A mutation can reverse mitochondrial dysfunction in a cellular model.

Main Methods:

• Utilized a monocyte-like cell line (TC-HSMAM1) harboring the m.15059G>A mtDNA mutation.
• Employed MitoCas9 technology to selectively remove mtDNA with the m.15059G>A mutation.
• Assessed mitochondrial membrane potential, reactive oxygen species (ROS) generation, lipid peroxidation, and oxygen consumption rate.

Main Results:

• Elimination of the m.15059G>A mutation significantly increased mitochondrial membrane potential and efficiency.
• Reduced generation of ROS and lipid peroxidation was observed after mutation removal.
• Mitochondrial genome editing improved cellular bioenergetic parameters without altering the antioxidant system.

Conclusions:

• The m.15059G>A mutation directly contributes to mitochondrial dysfunction in atherosclerosis.
• Restoring mitochondrial function by eliminating the pathogenic mtDNA mutation improves cellular health and bioenergetics.
• This study provides evidence for targeting mtDNA mutations to treat atherosclerosis-related mitochondrial dysfunction.